Center for Disease Analysis Foundation is pleased to announce 1.8 million dollars in the second round of grants. The following 11 organizations are beneficiaries: Boston Health Care for the Homeless Program? Central City Concern Community HealthNet Iowa Department of Health and Human Services Montefiore Medical Center Mount Sinai, Icahn School of Medicine Prisma Health Sentara Martha Jefferson Hospital University of Colorado Anschutz Medical Campus University of Miami Miller School of Medicine? University of Southern California “This award will allow us to add a Re-Engagement Specialist to our team,” stated Cody Shafer-Fritz, Lead Prevention Services Coordinator at Iowa Department of Health and Human Services. “The person in this role will work to connect individuals to treatment in a variety of settings throughout Iowa HHS’s existing partnerships. Treatment is a core strategy of our efforts to end the HCV epidemic in Iowa. We look forward to increasing our capacity to support the health and well-being of Iowans impacted by HCV.” The CDAF-Relink program is sponsored by an eight-million-dollar grant from Gilead Sciences as part of Gilead’s Relink grant program. Around the world, relink programs have shown success in reconnecting HCV and HBV infected individuals to care. Challenges remain, nonetheless, the main ones being identifying infected individuals based on available medical records, successfully contacting them, and navigating personal and institutional barriers to care. Building on the successes and lessons learned from the ongoing efforts of round one grantees, round two and subsequent rounds will continue to implement evidence-based approaches, leveraging successful interventions and data collection models, while emphasizing knowledge and resource sharing. “Hepatitis B and C infections are now the leading cause of death globally among all infectious diseases, and we have all the tools to eliminate these infections in the United States,” commented Homie Razavi, the Managing Director of CDA Foundation. “Loss of diagnosed but untreated patients is a major public health barrier in the U.S. to achieving the viral hepatitis elimination targets. Our second round of grantees will work with general and marginalized populations to link an estimated 5,400 diagnosed but untreated HCV and HBV infected individuals back into physicians’ care. We are grateful for all 25 applicants who took the time to submit a grant and will work with the organizations who were not funded to update their proposals for the next round of funding.” A total of 24 organizations have received Relink grants so far. The call for round three proposals will open in August 2024 with proposals from state health agencies given a priority. For more information, please visit?https://lnkd.in/gkfvsV9d?or contact the CDAF-Relink program at?[email protected].
关于我们
WHO WE ARE CDA Foundation (CDAF) is a non-profit organization that specializes in the study of complex and poorly-understood diseases in order to provide countries and health authorities with the data and information to support good decision-making. Our team works with health authorities and experts in over 100 countries. We actively collaborate with more than 1,000 national experts—including NGOs, economists, Ministries of Health and Finance and key opinion leaders—to develop national strategies to increase health access. We are highly collaborative, fully transparent and have over 120 peer-reviewed journal articles in publications such as The Lancet, the Journal of Viral Hepatitis, and the Journal of Medical Economics.
- 网站
-
https://www.cdafound.org
Center for Disease Analysis Foundation的外部链接
- 所属行业
- 研究服务
- 规模
- 11-50 人
- 总部
- Lafayette,Colorado
- 类型
- 非营利机构
- 创立
- 2012
地点
-
主要
1120 W South Boulder Rd
US,Colorado,Lafayette,80026
Center for Disease Analysis Foundation员工
动态
-
With round one grants underway, CDAF is pleased to announce that the RFP for round two of the Relink grant is now open! Is your organization working to #relink diagnosed but untreated #HCV+ & #HBV+ people in the US to care? Visit https://lnkd.in/gC5KSYGM for more information.